Invention Grant
- Patent Title: TGR5 modulators and methods of use thereof
- Patent Title (中): TGR5调节剂及其使用方法
-
Application No.: US13854579Application Date: 2013-04-01
-
Publication No.: US09243027B2Publication Date: 2016-01-26
- Inventor: Roberto Pellicciari
- Applicant: Intercept Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: INTERCEPT PHARMACEUTICALS, INC.
- Current Assignee: INTERCEPT PHARMACEUTICALS, INC.
- Current Assignee Address: US NY New York
- Agency: Cooley, LLP
- Agent Ivor Elrifi
- Priority: EP07001143 20070119; EP07012079 20070620
- Main IPC: A61K31/575
- IPC: A61K31/575 ; C07J31/00 ; C07J9/00 ; C07J41/00
Abstract:
The invention relates to compounds of Formula A: or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators useful for the treatment of various diseases, including obesity, insulin sensitivity, inflammation, cholestasis, and bile desaturation.
Public/Granted literature
- US20140094443A1 TGR5 Modulators and Methods of Use Thereof Public/Granted day:2014-04-03
Information query
